Seattle Genetics Achieves Milestone under Antibody-Drug Conjugate Collaboration with Agensys, an Affiliate of Astellas

2 September 2010, 6:00 am

BOTHELL, Wash.----Seattle Genetics, Inc. announced today that it has achieved a milestone under its antibody-drug conjugate collaboration with Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc.... Read More »

More Topics from "News"

• Seabeck deaf-blind retreat draws worldwide guests
• SonoSite to Present at Stifel Nicolaus 2010 Healthcare Conference
• Mirina Looks for Court Order on Trademark Suit Ahead of Marina Expansion into microRNA Drugs
• Southern California high school football rankings
• EagleView Technologies™ Launches Solar Roofing Report
• MMG Leverages Comparative Rating Solutions to Drive Growth
• M. Soccer. Season Preview: Defenders
• Nautilus Insurance Group Licenses Vertafore PolicyIssuance
• SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products